Evidence map›Paper›PMID 31958696›Full record

ReviewMolecular therapy. Nucleic acids2020

N

Lina Liu, Yuwei Wang, Jie Wu, Jingwen Liu, Zongchang Qin, Hong Fan

Open access · goldAbstract readReview
In one paragraph

Review in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. mInterdisciplinary sciences, computational life sciences · 2026
    Article
  2. WTAP mediated mScience China. Life sciences · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. circATAD2 mitigates CD8Cancer immunology, immunotherapy : CII · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Physio-pathological effects of m6A modification and its potential contribution to melanoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lina LiuDepartment of Prosthodontics, Tianjin Stomatological Hospital, Hospital of Stomatology, NanKai University, Tianjin 300041, P.R. China.
Yuwei WangSchool of Stomatology, Qingdao University, Qingdao 266071, P.R. China.
Jie WuThe School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, P.R. China.
Jingwen LiuThe School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, P.R. China. Electronic address: liujingwen@tmu.edu.cn.
Zongchang QinDepartment of Prosthodontics, Tianjin Stomatological Hospital, Hospital of Stomatology, NanKai University, Tianjin 300041, P.R. China. Electronic address: wyw@qdu.edu.cn.
Hong FanDepartment of Prosthodontics, Tianjin Stomatological Hospital, Hospital of Stomatology, NanKai University, Tianjin 300041, P.R. China. Electronic address: afanhong@126.com.
Tianjin Stomatological Hospital · CNTianjin Medical University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among more than 100 types of identified RNA modification, N

Indexed as

cancerepigeneticsm(6)Atumor suppressor

Identifiers

PMID31958696
PMCPMC7005339
OpenAlexW2995756851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.